-+ 0.00%
-+ 0.00%
-+ 0.00%

ENVVENO MEDICAL CORP: COMPANY ENTERS THE SECOND HALF OF 2026 WITH TAILWINDS FROM AN FDA IDE APPROVAL

Reuters·07/31/2026 12:33:54

Please log in to view news